Download StudyGeneral

Study Overview

Title:
HIV self-testing for partners of women attending antenatal care in Central Uganda: Uptake and linkage to care post-test
Change History for Title
Changed On Previous Value
08/22/2019 HIV self-testing for partners of women attending antenatal care in Central Uganda: Uptake and linkage to care post-test (grant agreement No. TW2.2.28))
Study is 3ie funded:
Yes
Study ID:
RIDIE-STUDY-ID-5d5e5415031cc
Initial Registration Date:
03/10/2016
Last Update Date:
07/20/2022
Study Status:
Completed
Location(s):
Uganda
Change History for Location(s)
Changed On Previous Value
07/20/2022 Uganda
Abstract:

 We implemented a phased cluster randomized controlled trial among pregnant women attending ANC in Mpigi Health Centre Level 4 (HCIV), Entebbe and Nakaseke Hospitals to 1) determine the uptake of HIV testing in the male partner; and 2) assess the linkage to care among HIV positive partners across the two study arms. We randomized clinic days to intervention or control. Women in the control arm were given health education and encouraged to bring their partners to test at the facility. Women in the intervention arm were additionally given HIVST kits to deliver to their partners. We conducted structured interviews with women at baseline, month one and month three post-enrolment and with the men at one month and three months post women’s enrolment. We also conducted a long term follow up sub study on HIV positive men and discordant couples at six and up to 24 months post enrolment. The primary outcomes were self-reported HIV testing, linkage to care post-test as defined by self-reported registration at an HIV clinic, and strategies for coping with discordant status reported by either the woman or male partner across Month 1 and 3 follow-ups; and up to 24

Registration Citation:

Wanyenze, R., 2016. HIV self-testing for partners of women attending antenatal care in Central Uganda: Uptake and linkage to care post-test. Registry for International Development for Impact Evaluations (RIDIE). Available at: 10.23846/ridie084

Categories:
Health, Nutrition, and Population
Additional Keywords:
HIV, HIV self-testing, partner testing, antenatal care, PMTCT, Uganda
Secondary ID Number(s):
TW2.2.28

Principal Investigator(s)

Name of First PI:
Rhoda Wanyenze
Affiliation:
Makerere University
Name of Second PI:
Jeffrey Korte
Affiliation:
Medical University of South Carolina

Study Sponsor

Name:
International Initiative for Impact Evaluation (3ie)
Study Sponsor Location:
United States

Research Partner

Name of Partner Institution:
Medical University of South Carolina
Type of Organization:
Research institute/University
Location:
United States
Intervention

Intervention Overview

Intervention:

The overall aim of the study is to determine the effect of HIV self-testing (HIVST) on uptake and outcomes of partner HIV testing, in a two-arm cluster randomized controlled trial that will evaluate the impact of providing HIV self-testing on the proportion of male partners being tested for HIV. The first arm is the control group arm, in which women will receive the standard of care including education for women to encourage their partners to test at the health facility. The second arm is the treatment arm, which will include standard of care plus the intervention of HIV self-testing kits.  The primary objectives include: 1) To determine the uptake of HIV testing and the number of new HIV infections identified in the two study arms; and 2) To assess the linkage care among HIV positive partners across the two study arms. Structured interviews will be conducted with 1500 women at baseline, 1-, and 3-months, and with their partners at 1-, and 3-months after enrollment of the women. Further, key informant interviews will be conducted with providers and in-depth interviews with selected family members of the enrolled women.

Private Intervention Details:
Theory of Change:

The theory of change that guided this study was based on several key assumptions. First, we assumed that the counseling and training provided to the women in the intervention arm would increase their motivation and self-efficacy to take the self-testing kits home and present them to their husbands. We assumed that having a self-testing kit would mitigate against common barriers to HIV testing among men, including lost work time, transportation costs, and stigma. We assumed that self-testing would reduce these barriers by increasing the man’s sense of privacy, convenience, and low cost associated with HIV testing, leading to an increased likelihood of HIV testing. Furthermore, we assumed that having an HIV kit would increase the man’s sense of self-efficacy, control, and ownership of the process of HIV testing, increasing the likelihood that he will test. Our theory of the health impact of testing rested on the assumption that men testing positive were able to link to care and that medication was available.

In previous research with pregnant women delivering kits to their male partners (Gichangi et al. 2017), we found that rates of couple testing were very high, and consequently rates of disclosure were very high. Thus, previous research supports the hypothesis that home-based self-testing may result in high rates of disclosure as well as linkage to care.

Based on our theory of change, we formulated hypotheses that the impact of the intervention might vary by age, marital status, education, and religious affiliation, because these factors could be related to the woman’s self-efficacy and motivation to bring the kit home and present it to the man, as well as the man’s likelihood to respond positively and test for HIV. In addition, we planned to test for differential effects by study site because these and other factors may differ across sites.

Multiple Treatment Arms Evaluated?
Yes

Implementing Agency

Name of Organization:
Makerere University School of Public Health
Type of Organization:
Research Institution/University

Program Funder

Name of Organization:
International Initiative for Impact Evaluation (3ie)
Type of Organization:
NGO (International)

Intervention Timing

Intervention or Program Started at time of Registration?
Yes
Start Date:
07/01/2016
End Date:
10/15/2018
Evaluation Method

Evaluation Method Overview

Primary (or First) Evaluation Method:
Randomized control trial
Other (not Listed) Method:
Additional Evaluation Method (If Any):
Regression with controls
Other (not Listed) Method:

Method Details

Details of Evaluation Approach:

Our primary analysis for estimating the impact of the intervention was to perform a comparison of the primary outcome (male partner testing) in the intervention group versus the control group. In addition to unadjusted analyses comparing these two groups, we fit log-linear models with and without accounting for clustering by clinic day, and testing for covariate imbalance at baseline. We accounted for clustering using a random effect for clinic day, because this was the unit of group-level randomization across clinics. In addition, we included study site as a fixed effect, and tested study site (as well as other pre-determined hypothesized effect modifiers) for multiplicative interactions with intervention assignment.

We used log-binomial models to allow estimation of the relative risk, which we judged the most appropriate measure of association in this longitudinal study with interval-based assessment of a high-prevalence outcome measure (HIV testing).

Private Details of Evaluation Approach:

The final analysis consisted of participants with sufficient follow-up data which needed them to have  completed at least one of the two follow-up interviews. To be included in the final analysis, participants. In random-effects log-binomial models accounting for clustering by clinic day, we estimated the risk ratio for HIV testing among male partners, comparing the two study arms. The primary outcome measure was the woman’s self-report about whether her male partner had tested for HIV since the beginning of the study. Overall, we also conducted analyses accounting for both the report of the women and men, by considering a man to have tested if either he or the woman reported that he had done so.

Outcomes (Endpoints):

Our primary outcomes were the woman’s report whether her primary partner tested for HIV within the three-month follow-up period after the first ANC visit; and linkage to care among HIV positive partners.

Secondary outcomes included the number of HIV infections identified in the two study arms, negative social outcomes, costing analysis of HIV self-testing and coping skills for discordant couples who self-tested for HIV.

Unit of Analysis:
Main unit of analysis is the individual patient
Hypotheses:

We hypothesize that the intervention group, Group 2 (HIVST), will have higher male partner testing rates than the comparison group (Group 1).

Unit of Intervention or Assignment:
The unit of intervention will be on the individual level.
Number of Clusters in Sample:
Our cluster was a clinic day across the three sites; 59 clusters from Nakaseke, in 108 clusters from Mpigi, and in 180 clusters from Entebbe.
Number of Individuals in Sample:
816 were recruited in the intervention arm and 742 in the control arm
Size of Treatment, Control, or Comparison Subsamples:
816 were recruited in the intervention arm and 742 in the control arm

Supplementary Files

Analysis Plan:
Other Documents:
Uganda ANC Study materials : ANC Uganda 3ie proposal_IRB.doc
training materials: CHECKLIST FOR THE PCR SUB STUDY _REVISED_MARCH 22 2017_Eng.docx
Quantitative materials: Quantitative informed consent form for women.docx
Manual: Interviewer Manual_HIVST_V3.doc
checklist for supervision: SUPERVISION CHECKLIST FOR HIVST STUDY.doc
Discrete choice experimentation: DCE Questionnaire_ C- PDF-11.11.2016.pdf
Discrete choice experimentation: DCE Questionnaire_ D- PDF-11.11.2016.pdf
Discrete choice experimentation: DCE Questionnaire_ PDF-A_11.11.2016.pdf
Discrete choice experimentation: DCE Questionnaire_ version B_ PDF-11.11.2016.pdf
Change History for Other Documents
Changed On Previous Value
07/20/2022 Description: Uganda ANC Study materials
Filename: ANC Uganda 3ie proposal_IRB.doc
Description: training materials
Filename: CHECKLIST FOR THE PCR SUB STUDY _REVISED_MARCH 22 2017_Eng.docx
Description: Quantitative materials
Filename: Quantitative informed consent form for women.docx
Description: Manual
Filename: Interviewer Manual_HIVST_V3.doc
Description: checklist for supervision
Filename: SUPERVISION CHECKLIST FOR HIVST STUDY.doc
Description: Discrete choice experimentation
Filename: DCE Questionnaire_ C- PDF-11.11.2016.pdf
Description: Discrete choice experimentation
Filename: DCE Questionnaire_ D- PDF-11.11.2016.pdf
Description: Discrete choice experimentation
Filename: DCE Questionnaire_ PDF-A_11.11.2016.pdf
07/20/2022 Description: Uganda ANC Study materials
Filename: ANC Uganda 3ie proposal_IRB.doc
Description: training materials
Filename: CHECKLIST FOR THE PCR SUB STUDY _REVISED_MARCH 22 2017_Eng.docx
Description: Quantitative materials
Filename: Quantitative informed consent form for women.docx
Description: Manual
Filename: Interviewer Manual_HIVST_V3.doc
Description: checklist for supervision
Filename: SUPERVISION CHECKLIST FOR HIVST STUDY.doc
Description: Discrete choice experimentation
Filename: DCE Questionnaire_ C- PDF-11.11.2016.pdf
Description: Discrete choice experimentation
Filename: DCE Questionnaire_ D- PDF-11.11.2016.pdf
07/20/2022 Description: Uganda ANC Study materials
Filename: ANC Uganda 3ie proposal_IRB.doc
Description: training materials
Filename: CHECKLIST FOR THE PCR SUB STUDY _REVISED_MARCH 22 2017_Eng.docx
Description: Quantitative materials
Filename: Quantitative informed consent form for women.docx
Description: Manual
Filename: Interviewer Manual_HIVST_V3.doc
Description: checklist for supervision
Filename: SUPERVISION CHECKLIST FOR HIVST STUDY.doc
Description: Discrete choice experimentation
Filename: DCE Questionnaire_ C- PDF-11.11.2016.pdf
07/20/2022 Description: Uganda ANC Study materials
Filename: ANC Uganda 3ie proposal_IRB.doc
Description: training materials
Filename: CHECKLIST FOR THE PCR SUB STUDY _REVISED_MARCH 22 2017_Eng.docx
Description: Quantitative materials
Filename: Quantitative informed consent form for women.docx
Description: Manual
Filename: Interviewer Manual_HIVST_V3.doc
Description: checklist for supervision
Filename: SUPERVISION CHECKLIST FOR HIVST STUDY.doc
07/20/2022 Description: Uganda ANC Study materials
Filename: ANC Uganda 3ie proposal_IRB.doc
Description: training materials
Filename: CHECKLIST FOR THE PCR SUB STUDY _REVISED_MARCH 22 2017_Eng.docx
Description: Quantitative materials
Filename: Quantitative informed consent form for women.docx
Description: Manual
Filename: Interviewer Manual_HIVST_V3.doc
07/20/2022 Description: Uganda ANC Study materials
Filename: ANC Uganda 3ie proposal_IRB.doc
Description: training materials
Filename: CHECKLIST FOR THE PCR SUB STUDY _REVISED_MARCH 22 2017_Eng.docx
Description: Quantitative materials
Filename: Quantitative informed consent form for women.docx
07/20/2022 Description: Uganda ANC Study materials
Filename: ANC Uganda 3ie proposal_IRB.doc
Description: training materials
Filename: CHECKLIST FOR THE PCR SUB STUDY _REVISED_MARCH 22 2017_Eng.docx
07/20/2022 Description: Uganda ANC Study materials
Filename: ANC Uganda 3ie proposal_IRB.doc
Data

Outcomes Data

Description:
The dataset is a merged health facility based dataset in STATA. It comprise data collected from 3 different sites at 3 phases of the study; main study, phase 2 and phase 3. The participants are assigned to either intervention or control arm
Data Already Collected?
Yes
Data Previously Used?
Yes
Data Access:
Not restricted - access with no requirements or minimal requirements (e.g. web registration)
Change History for Data Access
Changed On Previous Value
08/22/2019 Restricted -- Access requires a formal approval process
Data Obtained by the Study Researchers?
Yes
Data Approval Process:
Change History for Data Approval Process
Changed On Previous Value
08/22/2019 Write an email requesting for use of data to ; The Dean, Makerere University School of Public Health. P.O. Box 7072 Makerere Uganda
Approval Status:
Change History for Approval Status
Changed On Previous Value
08/22/2019 Yes-obtained approval and have received the data

Treatment Assignment Data

Participation or Assignment Information:
Yes
Description:
Data Obtained by the Study Researchers?
Data Previously Used?
Data Access:
Data Obtained by the Study Researchers?
Data Approval Process:
Approval Status:

Data Analysis

Data Analysis Status:
Yes
Change History for Data Analysis Status
Changed On Previous Value
08/22/2019 Yes

Study Materials

Upload Study Materials:
survey instruments: Survey instruments.doc

Registration Category

Registration Category:
Non-Prospective, Category 4: Data for measuring impacts have been obtained/collected by the research team and analysis for this evaluation has started
Completion

Completion Overview

Intervention Completion Date:
12/31/2018
Data Collection Completion Date:
10/15/2018
Unit of Analysis:
Individual
Clusters in Final Sample:
59 clusters (20.6%) from Nakaseke 108 clusters (34.5%) from Mpigi 180 clusters (44.9%) from Entebbe
Total Observations in Final Sample:
816 in the intervention arm and 742 in the control arm
Size of Treatment, Control, or Comparison Subsamples:
Intervention is 816; control is 742

Findings

Preliminary Report:
Yes
Preliminary Report URL:
https://doi.org/10.23846/TW2IE102
Summary of Findings:

HIV Self testing kits were delivered to partners by pregnant women attending antenatal care. We hypothesized that the intervention group (HIVST) would have significantly higher male partner testing rates than control. We randomized clinic days to intervention or control The primary outcomes were self-reported HIV testing, post-test linkage to care (defined by self-reported registration at an HIV clinic) reported by the woman or her male partner across the follow up period. We collected cost data to estimate the cost impact of HIVST, relative to public health benefits, and the corresponding cost to the medical system required to test an additional partner and detect each additional case of HIV. All primary outcomes are based on intention to treat. We recruited 1,618 women – 333 women in 59 clusters from Nakaseke, 558 women in 108 clusters from Mpigi and 727 women in 180 clusters from Entebbe. The mean age of the pregnant women was 25.2 years (SD = 5.5) and 32.2 years (SD = 8.1) male partners. There was an increase in male partner testing in the intervention arm, with a nearly four times higher proportion of male partners testing. Considering testing reports from the women and men, (76.7%) tested for HIV in the intervention versus 37.5% in the control group. Forty-two HIV positive men were identified in the intervention arm and 11 were identified in the control. Ten of 42 men in the intervention arm and 5 of 11 in the control group linked to care (p = 0.09). The total cost of the intervention was US$15,717.27, and US$5,826.10 (control). The cost per partner tested was US$30.30 (intervention) and US$31.20 (control), while the cost per HIV-infected person identified was US$462.30 (intervention) and US$582.60 (control). Our results demonstrated an increase in partner and couple HIV testing with oral self-testing, but do not show that men testing positive are as likely to link to care as those at a clinic.

Paper:
Yes
Paper Summary:

We implemented a cluster-randomized controlled trial comparing standard of care to intervention, with the primary outcome of self-reported male partner HIV testing. Women and male partners were followed at 1 and 3 months. We used unadjusted analyses and log-linear models with an intent-to-treat approach accounting for clustering.

Results: Study coordinators randomized 1514 women (777 interventions and 737 control). Baseline characteristics were balanced across arms with mean age (SD) of 25.2 (5.5) years and >44% with secondary education or higher. More male partners tested for HIV in intervention [576/746 (77.2%)] versus control [264/709 (37.2%)], P < 0.01. We identified 34 HIV-positive men in intervention versus 10 in control, with 6/26 (23%) and 4/6 (67%), respectively, reporting linking to care.

Conclusions: Our results demonstrate an enormous increase in self-reported partner HIV testing when HIVST is available at home. However, men testing positive through HIVST appeared less likely to link to care than men testing positive at a clinic. These results highlight the potential of HIVST in increasing HIV testing rates, while underscoring the importance of developing effective approaches to maximizing linkage to care among those testing positive through HIVST.

Paper Citation:
Korte JE, Kisa R, Vrana-Diaz CJ, Malek AM, Buregyeya E, Matovu JK, Kagaayi J, Musoke W, Chemusto H, Mukama SC, Ndyanabo A. HIV Oral self-testing for male partners of women attending antenatal care in central Uganda: uptake of testing and linkage to care in a randomized trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2020 Jul 1;84(3):271-9.

Data Availability

Data Availability (Primary Data):
Yes--Available now
Date of Data Availability:
Data URL or Contact:
rwanyenze@musph.ac.ug OR korte@musc.edu
Access procedure:
Write an email requesting for data to : Dr. Rhoda Wanyenze, Dean, Makerere University School of Public Health. P.O.Box 7072, Kampala

Other Materials

Survey:
Yes
Survey Instrument Links or Contact:
Program Files:
Yes
Program Files Links or Contact:
korte@musc.edu
External Link:
External Link Description:
Description of Changes:

Study Stopped

Date:
Reason: